Combination peptide therapy (e.g., GLP-1 agonists with other metabolic agents) may become better in the future as research evolves
However, if breakouts persist beyond six weeks, appear in unusual locations, or are accompanied by other symptoms like widespread redness or swelling, you're likely experiencing a true adverse reaction rather than purging
What to expect and when Most people notice reduced pain and inflammation first in weeks 1-3
Combination protocols at RWA GHK-Cu at RWA is frequently combined with other regenerative therapies to create a synergistic tissue repair environment: Microneedling + GHK-Cu: GHK-Cu applied immediately post-microneedling enhances collagen induction and accelerates recovery BPC-157 + GHK-Cu: complementary tissue repair BPC-157 for deeper tissue and internal healing, GHK-Cu for skin and connective tissue NAD+ IV therapy + GHK-Cu: NAD+ supports cellular energy production and DNA repair
Their primary therapeutic actions include stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying to promote satiety, and acting on hypothalamic appetite centers to reduce hunger and caloric intake
Injections are delivered with a small insulin-size needle into the subcutaneous fat, usually the abdomen or thigh, with daily site rotation to prevent tissue buildup